Advanced Biomed Statistics
Total Valuation
Advanced Biomed has a market cap or net worth of $9.09 million. The enterprise value is $8.13 million.
Important Dates
The last earnings date was Wednesday, November 19, 2025, after market close.
| Earnings Date | Nov 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Advanced Biomed has 21.64 million shares outstanding. The number of shares has increased by 4.68% in one year.
| Current Share Class | 21.64M |
| Shares Outstanding | 21.64M |
| Shares Change (YoY) | +4.68% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 80.97% |
| Owned by Institutions (%) | 1.21% |
| Float | 4.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.03 |
| P/TBV Ratio | 3.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.57.
| Current Ratio | 1.92 |
| Quick Ratio | 0.98 |
| Debt / Equity | 0.57 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -164.97% and return on invested capital (ROIC) is -53.08%.
| Return on Equity (ROE) | -164.97% |
| Return on Assets (ROA) | -35.28% |
| Return on Invested Capital (ROIC) | -53.08% |
| Return on Capital Employed (ROCE) | -94.59% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$109,042 |
| Employee Count | 31 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.45 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 47.76 |
| Average Volume (20 Days) | 1,701,440 |
Short Selling Information
The latest short interest is 1.16 million, so 5.36% of the outstanding shares have been sold short.
| Short Interest | 1.16M |
| Short Previous Month | 119,583 |
| Short % of Shares Out | 5.36% |
| Short % of Float | 28.15% |
| Short Ratio (days to cover) | 0.05 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.02M |
| Pretax Income | -3.38M |
| Net Income | -3.38M |
| EBITDA | -2.74M |
| EBIT | -3.02M |
| Earnings Per Share (EPS) | -$0.16 |
Full Income StatementBalance Sheet
The company has $2.66 million in cash and $1.70 million in debt, giving a net cash position of $954,641 or $0.04 per share.
| Cash & Cash Equivalents | 2.66M |
| Total Debt | 1.70M |
| Net Cash | 954,641 |
| Net Cash Per Share | $0.04 |
| Equity (Book Value) | 3.00M |
| Book Value Per Share | 0.14 |
| Working Capital | 2.80M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$6.41 million and capital expenditures -$13,443, giving a free cash flow of -$6.42 million.
| Operating Cash Flow | -6.41M |
| Capital Expenditures | -13,443 |
| Free Cash Flow | -6.42M |
| FCF Per Share | -$0.30 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
